Onego Bio, a leading Finnish biotech startup, has successfully raised €14 million to further its mission of revolutionising the egg protein market.
This funding comes just three months after the company’s successful Series A round, underscoring the potential of its innovative animal-free egg protein technology.
Meeting the Demand for Sustainable Egg Alternatives
Eggs are a staple in global food industries, yet the market is plagued by fluctuation due to factors like avian flu and rising demand for cage-free options. This instability challenges manufacturers to find consistent, reliable supplies of high-quality protein at affordable prices. Onego Bio is stepping in as a vital player, addressing these challenges with a long-term solution.
The startup, committed to rethinking egg production, offers a sustainable alternative to chicken eggs. The pursuit is clear: access to nutritious, tasty, and sustainable food without the ethical and environmental concerns of traditional egg farming.
By employing cutting-edge technology, Onego Bio aims to provide the market with superior protein products that meet both consumer expectations and regulatory standards, paving the way for a sustainable future in food production.
Innovative Technology Behind Onego Bio’s Success
Founded in 2022 as a spinoff from Finland’s VTT, Onego Bio is led by Maija Itkonen and Christopher Landowski. Their expertise in alternative proteins and fermentation technology is at the heart of their breakthrough innovation.
Onego Bio utilizes a patented fungal fermentation process to produce its flagship product, Bioalbumen®. This process has been shown to be highly productive and scalable, achieving industrial production potential of 120 g/L in massive fermentation vessels.
Bioalbumen® is bioidentical to ovalbumin, the primary protein in chicken egg whites. It not only contains all essential amino acids but also delivers impressive protein digestibility scores and a remarkable amount of protein per gram, proving it an excellent replacement for traditional egg proteins.
Expanding Manufacturing Capabilities
In collaboration with major food companies, Onego Bio is actively working on product formulations across various categories including baked goods, snacks, sauces, and meat alternatives.
Operating commercially in San Diego, California, Onego Bio is already producing Bioalbumen® with co-manufacturers as it plans for its own manufacturing facility.
This upcoming facility, with a massive two-million-liter fermentation capacity, is anticipated to match the protein production of six million laying hens, a testament to the scale and potential of Onego Bio’s technology.
Roadmap for Market Penetration in the EU
The recent investment from the European Innovation Council Accelerator Program will aid in Onego Bio’s strategic entry into the European market. This includes securing approval from the European Food Safety Authority, which is crucial for launching their product across Europe.
By aligning with regulatory requirements, Onego Bio ensures it meets the highest standards of food safety and quality, boosting consumer confidence and market acceptance.
Positive Impacts and Future Prospects
Leveraging its innovative technology, Onego Bio is not just a competitor but a pioneer in the alternative protein sector.
The company’s advancements promise not only to stabilise protein supplies in the face of market volatility but also to bring an eco-friendly, ethical choice to consumers.
With the support of its investors, Onego Bio is poised to scale up operations swiftly and efficiently, potentially reshaping the global protein market.
The Industry’s Perspective on Onego Bio
Onego Bio’s innovative approach has the potential to alter the landscape of protein production significantly.
With its recent infusion of funds, the company is well-positioned to make substantial strides in its mission to offer a viable alternative to traditional egg proteins.
In securing €14 million, Onego Bio underlines its role as a frontrunner in sustainable food innovation.
As it continues to evolve and expand, the company is set to leave a lasting impact on both the food industry and global sustainability efforts.
